Aker Biomarine AS (AKBM) — Cash Flow Reinvestment Rate
Aker Biomarine AS (AKBM) has a Cash Flow Reinvestment Rate of 4.14x as of December 2024, reinvesting Nkr31.50 Million (capex Nkr12.90 Million plus investments Nkr-18.60 Million) from operating cash flow of Nkr7.60 Million. Check AKBM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aker Biomarine AS Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Aker Biomarine AS across 8 annual periods. Explore AKBM operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Aker Biomarine AS (2016–2024)
Year-by-year capital reinvestment analysis for Aker Biomarine AS. For live market cap and broader valuation context, see AKBM market cap.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 32.99x | Nkr402.50 Million | Nkr12.20 Million | Nkr23.10 Million | ▲ +1492.5% |
| 2023 | 2.07x | Nkr98.20 Million | Nkr47.40 Million | Nkr49.30 Million | ▼ -69.5% |
| 2022 | 6.79x | Nkr102.50 Million | Nkr15.10 Million | Nkr46.10 Million | ▼ -96.9% |
| 2021 | 222.51x | Nkr162.21 Million | Nkr729.00K | Nkr81.11 Million | ▲ +2057.6% |
| 2019 | 10.31x | Nkr126.92 Million | Nkr12.31 Million | Nkr126.92 Million | ▲ +26.2% |
| 2018 | 8.17x | Nkr64.51 Million | Nkr7.89 Million | Nkr64.51 Million | ▼ -32.6% |
| 2017 | 12.12x | Nkr111.20 Million | Nkr9.17 Million | Nkr111.20 Million | ▲ +2222.5% |
| 2016 | 0.52x | Nkr10.90 Million | Nkr20.88 Million | Nkr10.90 Million | — |